Health Care · Biological Products, (No Diagnostic Substances) · Nasdaq · CIK 1598599 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.82Day +8.31%1Y −15.0%Off 52W high −30.8%Vol (1Y) 92.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,584 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.2% of sh out |
| Days to cover22.8d |
| 13F net flow (QoQ)−0.07% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)€9.0M |
| Earnings (TTM)-€49.2M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (EUR). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+4.0% |
| 1Y−15.0% |
| 3Y−38.1% |
| 5Y−44.5% |
| Since incept. (ann.)−15.7% |
Total return through 2026-07-29 · series begins 2020-04-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)92.1% |
| Ann. volatility (3Y)98.5% |
| Sharpe (1Y)0.17 |
| Sharpe (3Y)0.23 |
| Max drawdown (1Y)−50.8% |
| Max drawdown (3Y)−62.5% |
| Beta (3Y vs SPY)0.94 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Lion Point Capital, LP | 81,151 | $103,873 | 0.09% | +0.0% |
| MORGAN STANLEY | 43,524 | $55,711 | 0.05% | −6.2% |
| JANE STREET GROUP, LLC | 43,365 | $55,507 | 0.05% | −53.2% |
| MILLENNIUM MANAGEMENT LLC | 10,064 | $12,882 | 0.01% | −50.4% |
| RHUMBLINE ADVISERS | 4,734 | $6,057 | 0.01% | −9.0% |
| UBS Group AG | 861 | $1,102 | 0.00% | −9.1% |
| GAMMA Investing LLC | 240 | $307 | 0.00% | −77.6% |
| Farther Finance Advisors, LLC | 10 | $14 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for IPHA.
